0012B |
Acebutolol, Blood |
0012SP |
Acebutolol, Serum/Plasma |
0080B |
Acetone, Blood |
0080FL |
Acetone, Fluid |
0080SP |
Acetone, Serum/Plasma |
0080U |
Acetone, Urine |
0315B |
Amlodipine, Blood |
0315SP |
Amlodipine, Serum/Plasma |
0483B |
Atenolol, Blood |
0483SP |
Atenolol, Serum/Plasma |
0483TI |
Atenolol, Tissue |
0483U |
Atenolol, Urine |
1038B |
Ethylene Glycol Monobutyl Ether, Blood |
1038SP |
Ethylene Glycol Monobutyl Ether, Serum/Plasma |
1039B |
Ethylene Glycol Monoethyl Ether, Blood |
1039SP |
Ethylene Glycol Monoethyl Ether, Serum/Plasma |
1250B |
Chlorthalidone, Blood |
1250SP |
Chlorthalidone, Serum/Plasma |
1275B |
Clonidine, Blood |
1275SP |
Clonidine, Serum/Plasma |
1275U |
Clonidine, Urine |
1407B |
Cyclohexane, Blood |
1409B |
Cyclohexanone, Blood |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
1476B |
Delta-8 Cannabinoids Panel (DUID/DRE), Blood (Forensic) |
1479B |
Delta-8 and Delta-9 Cannabinoids Panel (DUID/DRE), Blood (Forensic) |
1546B |
Dichlorobenzenes, Blood |
1546SP |
Dichlorobenzenes, Serum/Plasma |
1550B |
Dichloroethane, Blood |
1560B |
Dichloromethane and Carboxyhemoglobin, Blood |
1561B |
Dichloromethane, Blood |
1561U |
Dichloromethane, Urine |
1640B |
Diltiazem, Blood |
1640SP |
Diltiazem, Serum/Plasma |
1640U |
Diltiazem, Urine |
1690B |
Dimethylsulfoxide, Blood |
1690SP |
Dimethylsulfoxide, Serum/Plasma |
1690U |
Dimethylsulfoxide, Urine |
1815B |
Doxazosin, Blood |
1815SP |
Doxazosin, Serum/Plasma |
1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861B |
Drugs of Abuse Screen (7 Panel), Blood |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864B |
Drugs of Abuse Screen (11 Panel), Blood |
1864FL |
Drugs of Abuse Screen (11 Panel), Fluid |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864TI |
Drugs of Abuse Screen (11 Panel), Tissue |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874B |
Drug Screen (10 Panel), Blood |
1874U |
Drug Screen (9 Panel), Urine |
1876B |
Drug Screen - Expanded, Blood |
1876FL |
Drug Screen - Expanded, Fluid |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
2022SP |
Eplerenone, Serum/Plasma |
2055B |
Ethylene Glycol Overexposure Profile, Blood |
2055SP |
Ethylene Glycol Overexposure Profile, Serum/Plasma |
2062B |
Ethylene Glycol, Blood |
2062FL |
Ethylene Glycol, Fluid |
2062SP |
Ethylene Glycol, Serum/Plasma |
2062TI |
Ethylene Glycol, Tissue |
2062U |
Ethylene Glycol, Urine |
2140B |
Furosemide, Blood |
2140SP |
Furosemide, Serum/Plasma |
2140U |
Furosemide, Urine |
2165B |
Glycols Panel, Blood |
2165FL |
Glycols Panel, Fluid |
2165LI |
Glycols Panel, Liquid |
2165SP |
Glycols Panel, Serum/Plasma |
2165TI |
Glycols Panel, Tissue |
2165U |
Glycols Panel, Urine |
2186B |
Guanfacine, Blood |
2186SP |
Guanfacine, Serum/Plasma |
2186U |
Guanfacine, Urine |
2270B |
Heptane, n-, Blood |
2270SP |
Heptane, n-, Serum/Plasma |
2290B |
Hexane, n-, Blood |
2290SP |
Hexane, n-, Serum/Plasma |
2292U |
n-Hexane Exposure Monitoring, Urine |
2308SP |
Hydralazine, Serum/Plasma |
2330B |
Hydrochlorothiazide, Blood |
2330SP |
Hydrochlorothiazide, Serum/Plasma |
2330U |
Hydrochlorothiazide, Urine |
2488B |
Labetalol, Blood |
2488FL |
Labetalol, Fluid |
2488SP |
Labetalol, Serum/Plasma |
2760ME |
Methadone and Metabolite (Qualitative), Meconium |
2980B |
Methyl n-Butyl Ketone, Blood |
2984U |
Methyl n-Butyl Ketone Exposure Monitoring, Urine |
3042B |
Metolazone, Blood |
3042SP |
Metolazone, Serum/Plasma |
3043B |
Metoprolol, Blood |
3043FL |
Metoprolol, Fluid |
3043SP |
Metoprolol, Serum/Plasma |
3043U |
Metoprolol, Urine |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3103B |
Nadolol, Blood |
3103SP |
Nadolol, Serum/Plasma |
3103U |
Nadolol, Urine |
3158B |
Nifedipine, Blood |
3158SP |
Nifedipine, Serum/Plasma |
3788B |
Prazosin, Blood |
3788SP |
Prazosin, Serum/Plasma |
4000B |
Propranolol, Blood |
4000FL |
Propranolol, Fluid |
4000SP |
Propranolol, Serum/Plasma |
4000TI |
Propranolol, Tissue |
4000U |
Propranolol, Urine |
4030B |
Pyridine, Blood |
4030SP |
Pyridine, Serum/Plasma |
4030U |
Pyridine, Urine |
4329B |
Terazosin, Blood |
4329SP |
Terazosin, Serum/Plasma |
4355B |
Tetrahydrofuran, Blood |
4355SP |
Tetrahydrofuran, Serum/Plasma |
4355U |
Tetrahydrofuran, Urine |
4482B |
Timolol, Blood |
4482SP |
Timolol, Serum/Plasma |
4510B |
Toluene, Blood |
4513U |
Toluene Exposure, Urine |
4540B |
Triamterene, Blood |
4540SP |
Triamterene, Serum/Plasma |
4770B |
Verapamil, Blood |
4770FL |
Verapamil, Fluid |
4770SP |
Verapamil, Serum/Plasma |
4770TI |
Verapamil, Tissue |
4770U |
Verapamil, Urine |
4830B |
Yohimbine, Blood |
4830SP |
Yohimbine, Serum/Plasma |
4830U |
Yohimbine, Urine |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6946H |
Drugs of Abuse Screen (9 Panel), Hair |
8030B |
Drug Facilitated Crime Panel, Blood (Forensic) |
8030SP |
Drug Facilitated Crime Panel, Serum/Plasma (Forensic) |
8030U |
Drug Facilitated Crime Panel, Urine (Forensic) |
8041B |
Postmortem, Basic w/Vitreous Alcohol Confirmation, Blood (Forensic) |
8050U |
Postmortem, Urine Screen Add-On (6-MAM Quantification only) (Forensic) Overview: Add-On Test |
8051B |
Postmortem, Basic, Blood (Forensic) |
8051FL |
Postmortem, Basic, Fluid (Forensic) |
8051SP |
Postmortem, Basic, Serum/Plasma (Forensic) |
8051TI |
Postmortem, Basic, Tissue (Forensic) |
8051U |
Postmortem, Basic, Urine (Forensic) |
8061B |
Postmortem, Basic w/o Alcohol, Blood (Forensic) |
8061TI |
Postmortem, Basic w/o Alcohol, Tissue (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol) (Qualitative), Urine (Forensic) |
8071U |
DUID/DRE Panel (Qualitative), Urine (Forensic) |
8083B |
Postmortem, Basic w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
8150B |
DUID/DRE Panel, Blood (Forensic) |
8151B |
DUID/DRE Panel (w/Alcohol), Blood (Forensic) |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8170U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
8171U |
DUID/DRE Panel, Urine (Forensic) |
8670ME |
Opiates - Total (Conjugated/Unconjugated) (Qualitative), Meconium |
8894OF |
Methadone and Metabolite (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9247B |
Propranolol Screen, Blood |
9247SP |
Propranolol Screen, Serum/Plasma |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |